Background {#Sec1}
==========

Remodeling of myocardium after infarction (MI) is linked to ventricular arrhythmias. \[[@CR1]\] It has been demonstrated that the presence of scar containing isthmuses of viable myocardium resulting in a heterogeneous zone (HZ) with altered conduction properties which may be part of the critical substrate for post-MI ventricular tachycardia. \[[@CR2], [@CR3]\] Late gadolinium-enhanced (LGE) imaging is used for MI visualization, clearly depicting infarct size and transmurality due to the excellent contrast achieved between scar and viable tissue. However, with LGE uncertainty can be introduced by contrast agent kinetics. \[[@CR4]\] Furthermore, LGE can lack information on tissue heterogeneity beyond \"gray\" areas that result from partial volume averaging and are assumed to be representative of the HZ. Conversely, scar tissue also exhibits increased T~2~, as fibrosis, primarily composed of collagen, increases interstitial water per unit volume. \[[@CR5]\] Hence, direct and quantitative measurement of T~2~ relaxation time may be a feasible alternative for delineating viable myocardium and fibrosis with the additional benefit of depicting tissue heterogeneity.

Hypothesis {#Sec2}
----------

High-resolution whole-heart 3D T~2~ mapping can assess tissue heterogeneity of chronic MI without contrast agents.

Methods {#Sec3}
=======

MI was induced in swine (N=3) by 2 hr balloon occlusion of the LAD after the first diagonal. MRI was carried out 4-6 months post MI (Achieva TX, Philips). Whole-heart 3D respiratory navigator-gated T~2~-mapping \[[@CR6]\] was performed. Serial gadolinium-enhanced images using PSIR \[[@CR7]\] were acquired at 3, 5, 10 and 20 min post infusion using 0.2 mmol/kg Gadolinium-based contrast (Magnevist). After final MRI, hearts were excised, imaged *ex vivo*, and post-mortem pathology and histology (H&E, Masson\'s Trichrome) were obtained.

Results {#Sec4}
=======

T~2~ maps showed excellent correlation with the myocardial distribution of infarct as evidenced by significantly and variably elevated T~2~ and the correlation with hyper-enhanced infarct area from LGE (PSIR 20 min post). Heterogeneity in the changes in signal intensity as a result of contrast agent kinetics was clearly visible on serial PSIR (3 - 20 min). LGE described the infarcted area uniformly, regardless of tissue heterogeneity. High spatial resolution T~2~ mapping enabled heterogeneity detection in and around the infarct area (Fig [1B,C,E](#Fig1){ref-type="fig"}). Histological images in Figure [2](#Fig2){ref-type="fig"} shows that collagen deposition penetrated into normal myocardium at the border zones of the MI, yet thin layers of viable myocardium remain within the infarct even after 6 months.Figure 1Matched representative SAX images from two swine 6 months post MI (Case \#1, A-C) and 4 months post MI (Case \#2, D-E). Image series A and D includes post-contrast PSIR and pre-contrast T~2~ map. The borders of the infarct (arrowhead and arrows) were magnified in series B, C and E. The contrast kinetics revealed by the PSIR images (3-10 min post) demonstrates that the infarct is in effect heterogeneous, while the LGE (PSIR 20 min) failed to visualize the heterogeneity. The pre-contrast T~2~ map identified the infarct and co-localized with LGE excellently, and preserved the tissue characteristics very well.Figure 2A. Masson\'s Trichrome staining of MI after 6 months (Case \#1 in Figure [1](#Fig1){ref-type="fig"}) depicts viable myocardium in red and fibrotic tissue in blue. B. Heterogeneous boundary of infarct demonstrates the mixture of viable tissue and fibrosis. C. Magnification of the isthmuses of viable myocardium mingled with fibrosis.

Conclusions {#Sec5}
===========

Images demonstrate that high-resolution 3D myocardial T~2~ mapping has the potential to noninvasively characterize chronic MI size, transmurality, and heterogeneity without exogenous contrast agents, providing an alternative for HZ determination beyond the traditional \"gray\" zone.
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